HK1222207A1 - 通過甲基化標記物來診斷癌症 - Google Patents

通過甲基化標記物來診斷癌症

Info

Publication number
HK1222207A1
HK1222207A1 HK16110261.3A HK16110261A HK1222207A1 HK 1222207 A1 HK1222207 A1 HK 1222207A1 HK 16110261 A HK16110261 A HK 16110261A HK 1222207 A1 HK1222207 A1 HK 1222207A1
Authority
HK
Hong Kong
Prior art keywords
diagnosis
cancer
methylation marker
methylation
marker
Prior art date
Application number
HK16110261.3A
Other languages
English (en)
Inventor
Ross Jason
Drew Horace
Laurence Molloy Peter
Mitchell Susan
Duesing Konsta
Xu Zheng-Zhou
Buckley Michael
Original Assignee
Clinical Genomics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010904116A external-priority patent/AU2010904116A0/en
Application filed by Clinical Genomics Pty Ltd filed Critical Clinical Genomics Pty Ltd
Publication of HK1222207A1 publication Critical patent/HK1222207A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HK16110261.3A 2010-09-13 2016-08-29 通過甲基化標記物來診斷癌症 HK1222207A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2010904116A AU2010904116A0 (en) 2010-09-13 Diagnostic method

Publications (1)

Publication Number Publication Date
HK1222207A1 true HK1222207A1 (zh) 2017-06-23

Family

ID=45830862

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16110262.2A HK1222208A1 (zh) 2010-09-13 2016-08-29 通過甲基化標記物來診斷癌症
HK16110261.3A HK1222207A1 (zh) 2010-09-13 2016-08-29 通過甲基化標記物來診斷癌症

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16110262.2A HK1222208A1 (zh) 2010-09-13 2016-08-29 通過甲基化標記物來診斷癌症

Country Status (12)

Country Link
US (2) US20130338020A1 (zh)
EP (4) EP3508589B1 (zh)
JP (6) JP2013545437A (zh)
CN (2) CN103314114B (zh)
AU (2) AU2011301770B2 (zh)
BR (2) BR112013005929B1 (zh)
CA (3) CA3154149A1 (zh)
DK (4) DK3034629T3 (zh)
ES (3) ES2760919T3 (zh)
HK (2) HK1222208A1 (zh)
NZ (1) NZ608153A (zh)
WO (1) WO2012034170A1 (zh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012054975A1 (en) 2010-10-28 2012-05-03 Clinical Genomics Pty. Ltd. Method of microvesicle enrichment
CA2872867C (en) * 2012-05-11 2020-09-15 Clinical Genomics Pty Ltd Diagnostic gene marker panel for colorectal cancer
WO2013170314A1 (en) 2012-05-18 2013-11-21 Clinical Genomics Pty. Ltd. A method of screening for colorectal cancer
EP2698436A1 (en) * 2012-08-14 2014-02-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Colorectal cancer markers
ES2720195T3 (es) 2012-11-26 2019-07-18 Clinical Genomics Pty Ltd Un método de detección de metilación
JP2016201999A (ja) * 2013-08-26 2016-12-08 北海道公立大学法人 札幌医科大学 大腸癌を検出する方法
EP3126529B1 (en) 2014-03-31 2020-05-27 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
KR102461235B1 (ko) * 2014-06-04 2022-10-28 퀘스트 다이어그노스틱스 인베스트먼츠 인코포레이티드 결장직장암에 대한 메틸화된 마커
US10829820B2 (en) 2015-08-31 2020-11-10 The United States Government As Represented By The Secretary Of The Army Methods for molecularly characterizing cervical cell samples
EP3368688B1 (en) * 2015-10-30 2021-01-27 New England Biolabs, Inc. Compositions and methods for determining modified cytosines by sequencing
CN105543354B (zh) 2015-12-31 2019-07-26 广州市康立明生物科技有限责任公司 一种肿瘤分子检测/诊断试剂
CN106048091A (zh) * 2016-07-28 2016-10-26 海南国际旅行卫生保健中心 检测登革病毒成熟miRNA的成套引物与方法
CA3060553A1 (en) * 2017-04-19 2018-10-25 Singlera Genomics, Inc. Compositions and methods for detection of genomic variance and dna methylation status
IT201700072650A1 (it) * 2017-06-28 2018-12-28 Univ Degli Studi Cagliari Metodo per rilevare e/o per la prognosi di neoplasie del colon-retto
WO2019006269A1 (en) * 2017-06-30 2019-01-03 The Regents Of The University Of California METHODS AND SYSTEMS FOR ASSESSING METHYLATION OF DNA IN ACELLULAR DNA
CN107858430B (zh) * 2017-11-20 2019-01-04 武汉迈特维尔生物科技有限公司 一种用于诊断预示Her-2过表达型乳腺癌骨转移的基因诊断试剂盒
CN110511999A (zh) * 2018-05-22 2019-11-29 广州市康立明生物科技有限责任公司 肿瘤标志物、甲基化试剂、试剂盒及其应用
CN110511998A (zh) * 2018-05-22 2019-11-29 广州市康立明生物科技有限责任公司 肿瘤标志物、甲基化试剂、试剂盒及其应用
CN110511997A (zh) * 2018-05-22 2019-11-29 广州市康立明生物科技有限责任公司 肿瘤标志物、甲基化试剂、试剂盒及其应用
CN110512001A (zh) * 2018-05-22 2019-11-29 广州市康立明生物科技有限责任公司 肿瘤标志物、甲基化试剂、试剂盒及其应用
CN108753963A (zh) * 2018-06-01 2018-11-06 安徽达健医学科技有限公司 一种检测粪便脱落细胞dna甲基化状态用于分析大肠癌的试剂盒
CN111363814B (zh) * 2018-12-25 2023-12-19 广州康立明生物科技股份有限公司 基于dmrta2和foxd3基因的肺癌诊断试剂及试剂盒
CN111363811B (zh) * 2018-12-25 2024-02-02 广州康立明生物科技股份有限公司 基于foxd3基因的肺癌诊断剂及试剂盒
CN111363812B (zh) * 2018-12-25 2023-12-19 广州康立明生物科技股份有限公司 基于dmrta2基因的肺癌诊断剂及试剂盒
CN109371138B (zh) * 2018-12-29 2022-10-25 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep4
CN111662978B (zh) * 2019-03-08 2021-11-16 北京大学 结直肠癌的dna甲基化标志物以及利用其检测结直肠癌的方法和试剂盒
CN110055330B (zh) * 2019-04-30 2022-10-11 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep9及其应用
CN109971860B (zh) * 2019-04-30 2022-10-11 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep8及其应用
US11001898B2 (en) 2019-05-31 2021-05-11 Universal Diagnostics, S.L. Detection of colorectal cancer
US11396679B2 (en) * 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
CN110317871B (zh) * 2019-07-11 2022-06-07 广州康立明生物科技股份有限公司 一种基因标志物组合及其应用
CN110343764B (zh) 2019-07-22 2020-05-26 武汉艾米森生命科技有限公司 检测结直肠癌相关基因甲基化的检测试剂的应用和试剂盒
US11427874B1 (en) 2019-08-26 2022-08-30 Epi One Inc. Methods and systems for detection of prostate cancer by DNA methylation analysis
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
CN110699437B (zh) * 2019-11-11 2023-06-20 益善生物技术股份有限公司 人sdc2基因甲基化检测试剂盒
CN113930499B (zh) * 2020-06-29 2023-09-22 武汉艾米森生命科技有限公司 检测基因甲基化的试剂的应用以及结直肠癌诊断或辅助诊断试剂盒
WO2022002424A1 (en) * 2020-06-30 2022-01-06 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
IT202100029210A1 (it) 2021-11-18 2023-05-18 Univ Degli Studi Di Teramo MARCATORE PER LA DETERMINAZIONE DEL RISCHIO INFETTIVO DA SARS-CoV-2
CN114561465B (zh) * 2021-12-20 2024-01-26 上海锐翌生物科技有限公司 一种用于检测结直肠腺瘤的标志组合物及其早期诊断试剂
WO2024056008A1 (zh) * 2022-09-16 2024-03-21 江苏鹍远生物科技股份有限公司 鉴别癌症的甲基化标志物及应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
ATE295427T1 (de) 1996-06-04 2005-05-15 Univ Utah Res Found Überwachung der hybridisierung während pcr
AU7164998A (en) 1997-04-28 1998-11-24 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states
CA2349417A1 (en) * 1998-11-05 2000-05-11 Parker Hughes Institute Ikaros isoforms and mutants
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
DE10019058A1 (de) 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
US7348142B2 (en) * 2002-03-29 2008-03-25 Veridex, Lcc Cancer diagnostic panel
US20060199179A1 (en) * 2002-06-19 2006-09-07 Oncotherapy Science, Inc. Method for diagnosis of colorectal tumors
JP4384603B2 (ja) 2002-06-26 2009-12-16 コールド スプリング ハーバー ラボラトリー メチル化プロファイルを測定するための方法および組成物
JP3711984B2 (ja) 2003-02-14 2005-11-02 日産自動車株式会社 ハイブリッド車両の制御装置
JP4453297B2 (ja) 2003-05-27 2010-04-21 トヨタ自動車株式会社 車両用遊星歯車式多段変速機
CA2531451A1 (en) * 2003-06-23 2005-01-06 Epigenomics Ag Methods and nucleic acids for analyses of colorectal cell proliferative disorders
WO2007118704A2 (en) * 2006-04-17 2007-10-25 Epigenomics Ag Methods and nucleic acids for the detection of colorectal cell proliferative disorders
CN101688239A (zh) * 2007-02-12 2010-03-31 约翰·霍普金斯大学 结肠癌的早期检测和预后
WO2008103763A2 (en) * 2007-02-20 2008-08-28 Sequenom, Inc. Methods and compositions for cancer diagnosis and treatment based on nucleic acid methylation
EP2474627B1 (en) * 2007-02-21 2015-05-20 Oslo Universitetssykehus HF New markers for cancer
WO2009061890A1 (en) * 2007-11-08 2009-05-14 St. Jude Children's Research Hospital Methods and compositions for the diagnosis, prognosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia
WO2009078931A2 (en) * 2007-12-10 2009-06-25 Brandeis University Irf as a tumor suppressor and uses thereof
US10927415B2 (en) * 2008-11-26 2021-02-23 The Johns Hopkins University Methods for identifying cancer risk
US8048634B2 (en) * 2009-08-18 2011-11-01 National Defense Medical Center Cancer screening method

Also Published As

Publication number Publication date
JP6813242B2 (ja) 2021-01-13
DK3034628T3 (en) 2019-02-11
EP3034629A1 (en) 2016-06-22
JP2019000112A (ja) 2019-01-10
US20240052426A1 (en) 2024-02-15
CN105886657B (zh) 2019-11-01
EP3508589A1 (en) 2019-07-10
BR112013005929B1 (pt) 2021-02-09
CN105886657A (zh) 2016-08-24
CN103314114A (zh) 2013-09-18
WO2012034170A1 (en) 2012-03-22
AU2011301770B2 (en) 2015-11-26
ES2760919T3 (es) 2020-05-18
JP2021061840A (ja) 2021-04-22
AU2011301770A1 (en) 2013-03-28
JP2013545437A (ja) 2013-12-26
JP2017060474A (ja) 2017-03-30
CA2812115C (en) 2021-10-26
EP2616556B1 (en) 2018-12-26
CA2812115A1 (en) 2012-03-22
BR122020021163B1 (pt) 2021-03-16
EP3034628B1 (en) 2018-10-24
EP3034629B1 (en) 2019-09-04
BR112013005929A2 (pt) 2016-07-05
DK3508589T3 (da) 2023-06-06
CA3154149A1 (en) 2012-03-22
ES2715226T3 (es) 2019-06-03
JP2020031638A (ja) 2020-03-05
HK1222208A1 (zh) 2017-06-23
JP6673562B2 (ja) 2020-03-25
US20130338020A1 (en) 2013-12-19
DK3034629T3 (da) 2019-12-02
AU2020202747A1 (en) 2020-05-21
EP3034628A1 (en) 2016-06-22
DK2616556T3 (en) 2019-04-08
CA3102758A1 (en) 2012-03-22
DK3034628T5 (en) 2019-02-18
JP2022084672A (ja) 2022-06-07
EP2616556A1 (en) 2013-07-24
JP7035156B2 (ja) 2022-03-14
EP3508589B1 (en) 2023-03-01
NZ608153A (en) 2014-12-24
AU2020202747B2 (en) 2022-05-26
CN103314114B (zh) 2016-08-10
ES2707341T3 (es) 2019-04-03
EP2616556A4 (en) 2014-02-26
CA3102758C (en) 2023-09-05

Similar Documents

Publication Publication Date Title
HK1222207A1 (zh) 通過甲基化標記物來診斷癌症
EP2701722A4 (en) CANCEROUS MARKERS OF HUMAN SUPPRESSIVE MYELOID CELLS
HK1203091A1 (zh) 用於診斷肺癌的組合物,方法和試劑盒
EP2593795A4 (en) DIAGNOSIS IN COLORECTAL CANCER
EP2617730A4 (en) IDENTIFICATION MARKER FOR LUNG CANCER
GB201016139D0 (en) Cancer phosholipidome
IL225441A0 (en) Breast cancer diagnostics
EP2625292A4 (en) KREBSBIOMARKER
EP2748608A4 (en) LUNG CANCER TESTS
HK1166130A1 (zh) 作為癌症標誌物的應用
EP2707710A4 (en) DIAGNOSIS OF CANCER
EP2524702A4 (en) DIAGNOSTIC TO CANCER
HUE064419T2 (hu) Marker anyagok alkalmazásai
GB201012590D0 (en) Methods for diagnosing cancer
EP2577298A4 (en) Diagnosis of cancer
GB201003293D0 (en) Cancer vaccine
ZA201200888B (en) New tumor marker
HK1199475A1 (zh) 診斷性標誌物
EP2585115A4 (en) ANTICANCER TREATMENT
EP2522366A4 (en) TARGETING AGENT FOR TUMOR SITE
HK1184221A1 (zh) 作為厄洛替尼治療的標誌物的 複合物
HK1165204A1 (zh) 作為肺癌標誌物的
GB2494830B (en) Underwater marker
PL2568796T3 (pl) Półzawieszany pług obracalny
EP2732287A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER